Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|August 17, 2000
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancerP M Schneider, H W Praeuer, O Stoeltzing, et al.
Anticancer Research|July 1, 1982
Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferonW Siegert, H Theml, U Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagusP M Schneider, O Stoeltzing, J A Roth, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeksM Fromm, W E Berdel, H D Schick, et al.
International Journal of Oncology|September 24, 1999
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopyF Noack, D Helmecke, R Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalitiesM Sarbia, M Stahl, A zur Hausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imagingW A Weber, K Ott, K Becker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trialB L D M Brücher, H J Stein, F Zimmermann, et al.
Laryngologie, Rhinologie, Otologie|August 1, 1982
[Head and neck cancers. What's new in clinical oncology for the practicing ENT physician?]W Schwab, S Feuerbach, L Schmid, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Pageof 21